• Hendrik Bracht, Enrico Calzia, Michael Georgieff, Joel Singer, Peter Radermacher, and James A Russell.
• Klinik für Anästhesiologie, Universitätsklinikum, Ulm, Germany.
• Br. J. Pharmacol. 2012 Apr 1; 165 (7): 2009-11.

AbstractCirculatory shock is characterized by arterial hypotension requiring fluid resuscitation combined with inotropes and/or vasopressors to correct the otherwise life-threatening impairment of oxygen supply to peripheral tissues. Catecholamines represent the current therapeutic choice, but this standard is only based on empirical clinical experience. Although there is evidence that some catecholamines may be better than others, it is a matter of debate which one may be the most effective and/or the safest for the different situations. In their review in this issue of the British Journal of Pharmacology, Bangash et al. provide an overview of the pharmacology as well as the available clinical data on the therapeutic use of endogenous catecholamines, their synthetic derivatives and a range of other agents (vasopressin and its analogues, PDE inhibitors and levosimendan). The authors point out that, despite well-established receptor pharmacology, the clinical effects of these treatments are poorly understood. Hence, further investigations are essential to determine which catecholamine, or, in a broader sense, which alternative vasopressor and/or inotrope is the most appropriate for a particular clinical condition.© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

9 keywords...

hide…